Status:
COMPLETED
Pharmacokinetic Effect of AstraGin on Whey Protein Absorption and Muscle Function in Healthy Subjects
Lead Sponsor:
Chung Shan Medical University
Conditions:
Pharmacokinetic Effect of AstraGin on Whey Protein Absorption and Muscle Function in Healthy Subjects
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
This study gave healthy people supplements with ginseng and astragalus saponin extracts (AstraGin), combined with whey protein, to explore whether it can promote amino acid absorption and thereby enha...
Detailed Description
A randomized-double blind, crossover human trial. 30 healthy adults, subdivided into two groups, are randomized into treatments and placebo groups to ensure equally balanced randomization and comparab...
Eligibility Criteria
Inclusion
- Healthy adults and aged 20-65 years.
- Subject has provided written informed consent to participate in the study.
- The subject is willing and able to comply with the study.
Exclusion
- The subject is participating in another clinical trial thirty days prior to enrollment.
- Subject allergy to milk proteins
- Subject has diabetes, obesity, hypertension, cardiovascular disease, liver or kidney disease, current infections, and smoking were exclusion criteria.
- Subject has any medical condition or uses any medication, nutritional product, amino acids supplement, or program which might interfere with the conduct of the study or place the subject at risk.
- Subjects lost to follow-up, non-compliance, and concomitant medication.
Key Trial Info
Start Date :
March 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06110260
Start Date
March 30 2024
End Date
October 30 2024
Last Update
December 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chung Shan Medical University
Taichung, Taiwan